[Suppression of allergic reactions with spirasidin].
D000707:Anaphylaxis / Q000517:prevention & control*; D000814:Aniline Compounds / Q000627:therapeutic use; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003877:Dermatitis, Contact / Q000276:immunology; D004195:Disease Models, Animal; D006168:Guinea Pigs; D007108:Immune Tolerance; D007942:Leukemia, Experimental / Q000188:drug therapy; D012513:Sarcoma, Experimental / Q000188:drug therapy; D012867:Skin / Q000473:pathology; D012882:Skin Tests
D000814:Aniline Compounds; D000970:Antineoplastic Agents
Unterdrückung allergischer Reaktionen mit Spirasidin.